Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 12:05:49 GMT 2023
by
admin
on
Sat Dec 16 12:05:49 GMT 2023
|
| Protein Type | RECEPTOR |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
7Q6KJ2Q69D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Q03431
Created by
admin on Sat Dec 16 12:05:49 GMT 2023 , Edited by admin on Sat Dec 16 12:05:49 GMT 2023
|
PRIMARY | |||
|
7Q6KJ2Q69D
Created by
admin on Sat Dec 16 12:05:49 GMT 2023 , Edited by admin on Sat Dec 16 12:05:49 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_91 |
| 1_82 | 1_122 |
| 1_105 | 1_144 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_125 |
| N | 1_135 |
| N | 1_140 |
| N | 1_150 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
AGONIST -> TARGET |
This results in activation of the cAMP signaling pathway in target cells. In rats and monkeys, abaloparatide had an anabolic effect on bone, demonstrated by increases in BMD and bone mineral content (BMC) that correlated with increases in bone strength at vertebral and/or nonvertebral sites.
ACTIVATOR
EC50
|
||
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET | |||
|
|
AGONIST -> TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|